ஹென்றிக் ஸ்டீன் ஜென்சன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹென்றிக் ஸ்டீன் ஜென்சன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹென்றிக் ஸ்டீன் ஜென்சன் Today - Breaking & Trending Today

Novo Nordisk plots $82M tablet capacity upgrade for diabetes blockbuster-to-be Rybelsus

Feb 25, 2021 9:41am
Novo Nordisk s oral Ozempic follow-up, Rybelsus, managed to pull $303 million in 2020 sales. (Novo Nordisk)
Novo Nordisk didn’t let the pandemic scupper the launch of its oral diabetes drug Rybelsus last year. Now, with strong sales on the docket, it’s pledging millions to expand future capacity for the blockbuster-in-waiting.
Novo Nordisk plans to spend 500 million Danish kroner ($82 million) to expand its production facility in Måløv, Denmark. The plant currently turns out Rybelsus, Novo’s oral semaglutide follow-up to its injectable Type 2 diabetes drug Ozempic.
The project, which is expected to wrap in 2022, will lock up future tablet production capacity for Rybelsus. Novo didn’t say what its final capacity would be when the expansion is complete. ....

Karsten Munk Knudsen , Novo Rybelsus , Lars Fruergaard , Henrik Steen Jensen , Novo Nordisk , New Jersey Based Emisphere Technologies , Ozempic Semaglutide , Covid 19 , Type 2 Diabetes , Diabetes Drug , Oral Tablets , Manufacturing Expansion , Manufacturing Plant , கார்ஸ்டன் மஂக் நட்‌ஸெந் , ஹென்றிக் ஸ்டீன் ஜென்சன் , நீரிழிவு நோய் , நீரிழிவு நோய் மருந்து , வாய்வழி மாத்திரைகள் , உற்பத்தி விரிவாக்கம் , உற்பத்தி ஆலை ,

Novo Nordisk invests in facility expansion at production site in Denmark

Novo Nordisk invests in facility expansion at production site in Denmark
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Henrik Steen Jensen , Novo Nordisk , ஹென்றிக் ஸ்டீன் ஜென்சன் ,